Anchun International Holdings Ltd. (SGX:BTX)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions SGD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 12, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	18	15	13	13	11	11
Market Cap Growth	31.58%	14.04%	0.70%	20.89%	-3.09%	-26.16%
Enterprise Value	-19	-20	-17	-21	-14	-11
Last Close Price	0.39	0.30	0.27	0.25	0.20	0.21
PE Ratio	5.37	7.45	30.05	2.26	-	-
PS Ratio	0.56	0.46	0.54	0.37	0.47	0.60
PB Ratio	0.33	0.26	0.24	0.23	0.19	0.20
P/TBV Ratio	0.33	0.26	0.24	0.23	0.19	0.20
P/FCF Ratio	-	4.31	7.53	2.55	1.35	4.58
P/OCF Ratio	-	3.78	4.91	2.41	1.22	3.63
Debt / FCF Ratio	-	-	-	-	-	0.00
Asset Turnover	0.46	0.44	0.33	0.45	0.29	0.26
Inventory Turnover	5.20	5.69	3.66	4.08	2.62	2.75
Quick Ratio	3.77	3.17	3.25	2.96	2.28	3.41
Current Ratio	4.11	3.44	3.54	3.29	2.58	3.84
Return on Equity (ROE)	6.33%	3.59%	0.79%	10.48%	-0.74%	-3.99%
Return on Assets (ROA)	1.51%	0.29%	-0.94%	3.06%	-1.59%	-3.12%
Return on Capital (ROIC)	1.98%	0.39%	-1.25%	4.30%	-2.17%	-3.96%
Return on Capital Employed (ROCE)	3.10%	0.60%	-	6.60%	-	-
Earnings Yield	18.63%	13.43%	3.33%	44.34%	-3.96%	-20.37%
FCF Yield	-17.36%	23.22%	13.29%	39.27%	73.84%	21.84%
Dividend Yield	5.46%	7.36%	-	9.52%	-	-
Payout Ratio	28.98%	-	236.87%	-	-	-
Buyback Yield / Dilution	0.27%	0.64%	1.03%	1.05%	0.89%	3.00%
Total Shareholder Return	5.73%	8.00%	1.03%	10.57%	0.89%	3.00%

Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.